Export

Hydroxycarbamide
Essential medicine status
General description
Hydroxycarbamide (also known as hydroxyurea) is an antineoplastic antimetabolite used in treatment protocols for chronic myeloproliferative disorders, and in the management of sickle cell disease.
INN
Hydroxycarbamide
Medicine type
Chemical agent
Therapeutic equivalent for
Recommendations
Section
Cytotoxic medicines
  • Oral > Solid: 200 mg; 250 mg; 300 mg; 400 mg; 500 mg; 1 g
Section
Other medicines for haemoglobinopathies
  • Oral > Solid: 200 mg; 500 mg; 1 g